Y Biologics
Scope
Date
~
-
Bio & Pharma
Lotte to invest more in US bio biz, spend $3 bn in Korea
SAN FRANCISCO -- South Korea’s Lotte Biologics Co. is considering investing more in the US bio industry and spending $3 billion in new factori...
Jan 11, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Biologics receives Terra Carta Seal
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it was awarded the Sustainable Markets Initiative’s Ter...
Jan 11, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Hansol Chemical to enter bio industry with BiOCS acquisition
Hansol Chemical Co., a unit of South Korea’s paper-focused conglomerate Hansol Group, is expanding its business scope to biomaterials by acqui...
Dec 27, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Samsung Chairman Jay Y. Lee flies to Vietnam for global business
Samsung Electronics Co. Chairman Jay Y. Lee embarked on a business trip to Vietnam on Wednesday to attend an opening ceremony for a research and dev...
Dec 21, 2022 (Gmt+09:00)
-
Executive reshuffles
Samsung Elec names first female president under Chairman Jay Y. Lee
Samsung Electronics Co., the world’s largest memory chip and smartphone maker, has carried out its year-end executive reshuffle, marked by its...
Dec 05, 2022 (Gmt+09:00)
-
Economy
Korea inflation at 7-mth low; BOK may slow rate hike pace
South Korea’s headline inflation hit a seven-month low in November as rises in agricultural and petroleum product prices slowed, adding to exp...
Dec 02, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics in CDO deal talks with global pharma firm
FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...
Nov 07, 2022 (Gmt+09:00)
-
Leadership & Management
Jay Y. Lee inaugurated as chairman of Samsung Electronics
Samsung Electronics Co.'s leader Jay Y. Lee was promoted as the company's chairman on Oct. 27.Samsung Electronics' board of directors approved the a...
Oct 27, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea's Samsung Biologics signs $296 mn CMO deal with GSK
South Korea’s Samsung Biologics Co. has signed a $296.1 million deal to supply biopharmaceutical products to UK-based multinational pharma gia...
Oct 21, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics opens the world's largest CDMO factory
South Korea’s Samsung Biologics Co.’s new biopharmaceuticals plant launched operations on Tuesday, a move expected to widen the gap betw...
Oct 11, 2022 (Gmt+09:00)
-
Shareholder value
Samsung leader Lee calls on mgt to raise shareholder value
Samsung Electronics Co. set up a task force team dedicated to increasing its shareholder value last month, according to industry sources on Oct. 4. ...
Oct 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Samsung C&T extends investment in US biotech firms
The Life Science Fund, jointly launched by Samsung Biologics and Samsung C&T Corp., announced Wednesday it invested $15 million in US biotech fi...
Aug 17, 2022 (Gmt+09:00)
-
Samsung Group
Samsung Group to speed up corporate governance reform
Samsung Group, South Korea’s largest conglomerate, is expected to accelerate the restructuring of its corporate governance to help Vice Chairm...
Aug 15, 2022 (Gmt+09:00)
-
Carbon neutrality
Samsung Electronics to announce plans to join RE100 Initiative
Samsung Electronics Co., the world’s largest smartphone and memory chipmaker, will soon join The Climate Group’s RE100 Initiative as the...
Aug 14, 2022 (Gmt+09:00)
-
Samsung Group
Samsung’s Lee reinstated; big moves in store for top conglomerate
Lee Jae-yong, Samsung Group’s de facto leader, on Friday had his right to work restored, paving the way for big moves for South Korea’s ...
Aug 12, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics to double CDMO capacity with new plants worth $5.3 bn
Samsung Biologics Co., the world’s largest contract drugmaker, plans to double its manufacturing capacity by building four additional plants w...
Jul 18, 2022 (Gmt+09:00)
-
Electric vehicles
Hyundai’s IONIQ 6 travels faster, farther than Tesla Model Y, Mercedes EQS
BUSAN – Hyundai Motor Co. has launched the IONIQ 6, its first fully electric sedan, which it claims runs faster and boasts a longer range than...
Jul 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Samsung Biologics eye record-high annual sales
South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...
Jul 08, 2022 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs $81 mn CMO deal with Novartis
South Korea’s Samsung Biologics Co. has inked an $81 million contract manufacturing deal with Novartis, the world’s fifth-largest pharma...
Jun 07, 2022 (Gmt+09:00)
language -
Korean chipmakers
Samsung Elec. executes surprise chip executive reshuffle
Samsung Electronics Co. undertook an unexpected personnel reshuffle on Thursday, involving 20 employees, to hold them accountable for a lower-than-e...
Jun 03, 2022 (Gmt+09:00)
language -
Business & Politics
Yoon, Biden highlight 'economic security alliance' following Samsung tour
South Korean President Yoon Suk-yeol and visiting US President Joe Biden emphasized the two countries' iron-clad commitment to economic security all...
May 20, 2022 (Gmt+09:00)
language -
Mergers & Acquisitions
Lotte to buy BMS' biologics plant in Syracuse for $160 mn
South Korea's Lotte Group has agreed to buy Bristol Myers Squibb's (BMS) biologics plant in Syracuse in the state of New York for $160 million, the ...
May 13, 2022 (Gmt+09:00)
-
The KED View
Time for Samsung to get another Fukuda Report
Eight years ago today, the late Samsung Group leader Lee Kun-hee collapsed at his home following a heart attack, a harbinger of doom six years later...
May 10, 2022 (Gmt+09:00)
-
Samsung Group
Jay Y. Lee absence raises risks for Samsung chip biz
Samsung Electronics Co. is losing its hegemony in the global semiconductor market as a sustained leadership vacuum has kept the world’s top me...
Apr 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Kolon Life inks technology transfer deal with Juniper Biologics
South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...
Apr 13, 2022 (Gmt+09:00)
-
Rights offerings
Samsung Biologics to raise $2.6 bn in rights issue
Samsung Biologics Co., a global contract development and manufacturing organization (CDMO) and a biotech division under the Samsung Group, is set ...
Apr 12, 2022 (Gmt+09:00)
-
Samsung Group
Samsung Group hires governance expert for unprecedented reorganization
Samsung Electronics Co. has hired a 20-year governance veteran for its much-awaited corporate governance restructuring, according to those familia...
Apr 11, 2022 (Gmt+09:00)
-
War in Ukraine
Korea jittery over oil, gas, commodity weaponization
South Korea’s energy and raw materials imports have surged to all-time highs in value terms in the wake of Russia’s invasion of Ukraine,...
Mar 13, 2022 (Gmt+09:00)
-
Private equity
IMM to buy Samsung Life stake once owned by Jay Y. Lee's sister
IMM Private Equity is set to acquire a 1.73 percent stake in Samsung Life Insurance Co., according to investment banking sources on Jan. 27. The sta...
Jan 27, 2022 (Gmt+09:00)
-
Electronics
Samsung Elec launches dedicated team for China
Samsung Electronics Co., South Korea’s top tech giant, has established a dedicated team for the Chinese market, where its smartphone and home ...
Dec 19, 2021 (Gmt+09:00)
language
Latest News
- 1 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 2 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 3 Woori Financial wins approval for Tongyang, ABL Life acquisition
- 4 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 5 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs